81 FR 79508 - Government-Owned Inventions; Availability for Licensing
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 219 (November 14, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 219 (November 14, 2016)
| Page Range | 79508-79508 | |
| FR Document | 2016-27222 |
[Federal Register Volume 81, Number 219 (Monday, November 14, 2016)] [Notices] [Page 79508] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-27222] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious commercialization of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892-2479; telephone: 301-402-5579. A signed Confidential Disclosure Agreement may be required to receive copies of the patent applications. SUPPLEMENTARY INFORMATION: Technology descriptions follow. Immortalized Organ of Corti Cell Line OC-k3 Description of Technology Available for nonexclusive licensing as a research material is a conditionally immortalized Organ of Corti cell line called OC-k3. Sensory cells from the auditory organ, the Organ of Corti, are terminally differentiated and cannot be cultured. Moreover, few of them can be isolated per cochlea and survive only few hours after isolation making impossible to use on them many biochemical and molecular biology techniques. OC-k3, expresses many markers of sensory cells and it has already been used as an in vitro model for a variety of studies. Potential Commercial ApplicationsResearch Hearing research Susceptibility to ototoxic drugs Development Stage Materials Inventors: Gilda Mabel Canseco de Kalinec and Federico Kalinec (both of NIDCD). Publications 1. Bertolaso L, et al. (2001) ``Apoptosis in the OC-k3 immortalized cell line treated with different agents.'' Audiology 40:327-335. PMID: 1178104637-5745. 2. Previati M, et al. (2007) ``Cisplatin cytotoxicity in Organ of Corti-derived immortalized cells.'' J Celt Biochem.101(5):1185-97, PMID: 7243113. Intellectual Property: HHS Reference No. E-012-2017/0--Research Material. Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; [email protected]. Dated: November 7, 2016. Michael Shmilovich, National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health. [FR Doc. 2016-27222 Filed 11-10-16; 8:45 am] BILLING CODE 4140-01-P
![79508 Federal Register / Vol. 81, No. 219 / Monday, November 14, 2016 / Notices
for Advancing Translational Sciences, 1 few hours after isolation making Citizenship and Immigration Services
Democracy Plaza, Room 1072, Bethesda, MD impossible to use on them many provides this notice in accordance with
20892, 301–435–0809, anna.ramseyewing@ biochemical and molecular biology the Privacy Act of 1974 (5 U.S.C. 552a),
nih.gov.
techniques. OC-k3, expresses many as amended by the Computer Matching
(Catalogue of Federal Domestic Assistance markers of sensory cells and it has and Privacy Protection Act of 1988
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry already been used as an in vitro model (Public Law 100–503) and the Computer
Research; 93.350, B—Cooperative for a variety of studies. Matching and Privacy Protection
Agreements; 93.859, Biomedical Research Amendments of 1990 (Public Law 101–
Potential Commercial Applications 508) (Privacy Act); Office of
and Research Training, National Institutes of
Health, HHS) • Research Management and Budget (OMB) Final
• Hearing research Guidance Interpreting the Provisions of
Dated: November 7, 2016.
• Susceptibility to ototoxic drugs Public Law 100–503, the Computer
David Clary,
Development Stage Matching and Privacy Protection Act of
Program Analyst, Office of Federal Advisory
1988, 54 FR 25818 (June 19, 1989); and
Committee Policy. • Materials appendix I to OMB’s Revision of
[FR Doc. 2016–27223 Filed 11–10–16; 8:45 am] Inventors: Gilda Mabel Canseco de
Circular No. A–130 (November 28,
BILLING CODE 4140–01–P Kalinec and Federico Kalinec (both of
2000), ‘‘Transmittal Memorandum No.
NIDCD).
4, Management of Federal Information
Publications Resources.’’
DEPARTMENT OF HEALTH AND Participating Agencies: The
HUMAN SERVICES 1. Bertolaso L, et al. (2001)
Department of Homeland Security, U.S.
‘‘Apoptosis in the OC-k3 immortalized
National Institutes of Health Citizenship and Immigration Services
cell line treated with different agents.’’
(DHS–USCIS) is the source agency and
Audiology 40:327–335. PMID:
Government-Owned Inventions; the New Jersey Department of Labor and
1178104637–5745.
Availability for Licensing 2. Previati M, et al. (2007) ‘‘Cisplatin Workforce Development (NJ–LWD) is
cytotoxicity in Organ of Corti-derived the recipient agency.
AGENCY: National Institutes of Health, Purpose of the Match: The purpose of
HHS. immortalized cells.’’ J Celt
this Agreement is to establish the terms
ACTION: Notice. Biochem.101(5):1185–97, PMID:
and conditions governing NJLWD’s
7243113.
access to, and use of, the DHS–USCIS
SUMMARY: The inventions listed below Intellectual Property: HHS Reference
Systematic Alien Verification for
are owned by an agency of the U.S. No. E–012–2017/0—Research Material.
Licensing Contact: Michael Entitlements (SAVE) Program, which
Government and are available for provides immigration status information
licensing in the U.S. in accordance with Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov. from Federal immigration records to
35 U.S.C. 209 and 37 CFR part 404 to authorized users, and to comply with
achieve expeditious commercialization Dated: November 7, 2016. the Computer Matching and Privacy
of federally-funded research and Michael Shmilovich, Protection Act of 1988.
development. Foreign patent National Heart, Lung and Blood Institute, New Jersey Department of Labor and
applications are filed on selected Office of Technology Transfer and Workforce Development will use the
inventions to extend market coverage Development, National Institutes of Health. SAVE Program to verify the immigration
for companies and may also be available [FR Doc. 2016–27222 Filed 11–10–16; 8:45 am] status of non U.S. citizens who apply for
for licensing. BILLING CODE 4140–01–P benefits (Benefit Applicants) under the
FOR FURTHER INFORMATION CONTACT: Unemployment Compensation (UC)
Licensing information and copies of the benefits that it administers. Under
U.S. patent applications listed below DEPARTMENT OF HOMELAND Federal law, immigrant workers must be
may be obtained by writing to the SECURITY in particular immigration categories to
indicated licensing contact at the qualify for UC benefits. NJLWD will use
National Heart, Lung and Blood Office of the Secretary the information obtained through the
Institute, Office of Technology Transfer SAVE Program to determine whether
[Docket No. DHS–2016–0083]
and Development, National Institutes of Benefit Applicants possess the requisite
Health, 31 Center Drive, Room 4A29, Privacy Act of 1974; Computer immigration status to be eligible for the
MSC2479, Bethesda, MD 20892–2479; Matching Program UC benefits administered by NJLWD.
telephone: 301–402–5579. A signed Authority for Conducting the
Confidential Disclosure Agreement may AGENCY: U.S. Citizenship and Matching Program: Section 121 of the
be required to receive copies of the Immigration Services, Department of Immigration Reform and Control Act
patent applications. Homeland Security. (IRCA) of 1986, Public Law 99–603, as
SUPPLEMENTARY INFORMATION: ACTION: Notice of Recertification. amended by the Personal Responsibility
Technology descriptions follow. and Work Opportunity Reconciliation
SUMMARY: This document provides Act of 1996 (PRWORA), Public Law
Immortalized Organ of Corti Cell Line notice of the existence of a computer 104–193, 110 Stat. 2168 (1996), requires
OC-k3 Description of Technology matching program between the DHS to establish a system for the
Available for nonexclusive licensing Department of Homeland Security, U.S. verification of immigration status of
mstockstill on DSK3G9T082PROD with NOTICES
as a research material is a conditionally Citizenship and Immigration Services alien applicants for, or recipients of,
immortalized Organ of Corti cell line and the New Jersey Department of Labor certain types of benefits as specified
called OC-k3. Sensory cells from the and Workforce Development, titled within IRCA, and to make this system
auditory organ, the Organ of Corti, are ‘‘Verification Division DHS–USCIS/NJ– available to state agencies that
terminally differentiated and cannot be LWD.’’ administer such benefits. Section 121(c)
cultured. Moreover, few of them can be SUPPLEMENTARY INFORMATION: The of IRCA amends sec. 1137 of the Social
isolated per cochlea and survive only Department of Homeland Security, U.S. Security Act and certain other sections
VerDate Sep<11>2014 17:26 Nov 10, 2016 Jkt 241001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 E:\FR\FM\14NON1.SGM 14NON1](https://thefederalregister.org/doc/81_FR_79727/page/1.svg)
Document Created: 2018-10-24 10:47:25
Document Modified: 2018-10-24 10:47:25
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892-2479; telephone: 301-402-5579. A signed Confidential Disclosure Agreement may be required to receive copies of the patent applications. | |
| FR Citation | 81 FR 79508 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR